ResearchSafe

SNAP-25 Fragment (SNAP-25 Inhibitory Fragment Peptide)

Category: Skin & Anti-Aging. Status: Research compound.

A targeted fragment peptide designed to specifically disrupt SNARE complex assembly for expression wrinkle reduction. Newer generation of neuromuscular anti-wrinkle peptides.

How it works

Directly competes with the SNAP-25 binding domain in SNARE complex formation, providing highly specific inhibition of vesicle fusion at facial neuromuscular junctions.

Key facts

  • Molecular weight: ~650 Da
  • Half-life: N/A (topical depot)
  • Bioavailability: Topical penetration ~6-9%
  • Storage: Room temperature, protect from heat.

Dosing overview

  • Typical dose: 3-8% in formulation
  • Frequency: 2x daily
  • Duration: 4-8 weeks
  • Route: Topical serum

Protocol notes

  • Used as a topical serum containing ~3-8% of the peptide, applied to expression-line areas (forehead, crow's feet).
  • Apply morning and night to clean, dry skin; let it absorb before other products.
  • Often layered with Argireline/SNAP-8 for complementary expression-line softening.

Reported benefits

  • Highly specific SNARE targeting
  • Expression line reduction
  • Improved selectivity
  • Complementary to Argireline

Possible side effects

  • Mild tingling
  • Rare irritation
  • Temporary tightness

Research

  • Next-generation SNARE-targeting peptides (2020): Demonstrated improved specificity for facial muscle relaxation vs first-generation SNAP-25 competitors.
  • Fragment-based approach to cosmetic peptides (2021): Smaller fragment size improved dermal penetration by 40% vs full-length competitors.

Compare SNAP-25 Fragment

Community discussions about SNAP-25 Fragment

Research and educational reference only. Not medical advice.